Dupont Capital Management Corp Charles River Laboratories International, Inc. Transaction History

Dupont Capital Management Corp

$889 Million
Q1 2025

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$183.71 - $210.25 $31,230 - $35,742	-170 Reduced 9.04%	1,710 $359,000
Q1 2023 Apr 28, 2023	SELL	$191.89 - $259.92 $402,969 - $545,832	-2,100 Reduced 52.76%	1,880 $379,000
Q4 2022 Jan 26, 2023	SELL	$197.11 - $250.07 $115,506 - $146,541	-586 Reduced 12.83%	3,980 $0
Q3 2022 Oct 31, 2022	SELL	$182.44 - $250.54 $134,093 - $184,146	-735 Reduced 13.87%	4,566 $899,000
Q2 2022 Jul 26, 2022	BUY	$204.13 - $302.4 $218,827 - $324,172	1,072 Added 25.35%	5,301 $1.13 Million
Q1 2022 Apr 27, 2022	SELL	$255.51 - $362.11 $96,327 - $136,515	-377 Reduced 8.18%	4,229 $1.2 Million
Q4 2021 Jan 31, 2022	SELL	$351.38 - $448.68 $541,476 - $691,415	-1,541 Reduced 25.07%	4,606 $1.74 Million
Q3 2021 Nov 03, 2021	SELL	$372.64 - $458.3 $1.2 Million - $1.48 Million	-3,219 Reduced 34.37%	6,147 $2.54 Million
Q2 2021 Jul 30, 2021	BUY	$294.17 - $371.65 $548,038 - $692,383	1,863 Added 24.83%	9,366 $3.47 Million
Q1 2021 Apr 29, 2021	SELL	$249.67 - $299.48 $1.84 Million - $2.21 Million	-7,371 Reduced 49.56%	7,503 $2.18 Million
Q4 2020 Jan 28, 2021	SELL	$222.0 - $252.62 $330,780 - $376,403	-1,490 Reduced 9.11%	14,874 $3.72 Million
Q3 2020 Oct 29, 2020	BUY	$175.56 - $226.45 $2.24 Million - $2.89 Million	12,764 Added 354.56%	16,364 $3.71 Million
Q2 2020 Jul 24, 2020	SELL	$118.84 - $189.72 $118,364 - $188,961	-996 Reduced 21.67%	3,600 $628,000
Q1 2020 Apr 29, 2020	SELL	$98.9 - $178.34 $287,502 - $518,434	-2,907 Reduced 38.74%	4,596 $580,000
Q4 2019 Jan 27, 2020	BUY	$126.05 - $152.76 $71,722 - $86,920	569 Added 8.21%	7,503 $1.15 Million
Q3 2019 Oct 28, 2019	BUY	$125.07 - $143.67 $248,639 - $285,615	1,988 Added 40.19%	6,934 $918,000
Q1 2019 Apr 30, 2019	BUY	$104.82 - $146.73 $55,764 - $78,060	532 Added 12.05%	4,946 $718,000
Q4 2018 Feb 01, 2019	SELL	$105.09 - $137.23 $421,305 - $550,155	-4,009 Reduced 47.6%	4,414 $500,000
Q2 2018 Jul 30, 2018	BUY	$102.37 - $117.25 $503,762 - $576,987	4,921 Added 140.52%	8,423 $946,000
Q1 2018 May 02, 2018	SELL	$98.19 - $115.2 $785,323 - $921,369	-7,998 Reduced 69.55%	3,502 $374,000
Q4 2017 Jan 31, 2018	BUY	$100.43 - $118.09 $258,808 - $304,317	2,577 Added 28.88%	11,500 $1.26 Million
Q3 2017 Oct 31, 2017	BUY	$96.72 - $109.26 $863,032 - $974,926	8,923	8,923 $964,000

Others Institutions Holding CRL

# of Institutions

699

Shares Held

50.7M

Call Options Held

122K

Put Options Held

239K

Vanguard Group Inc Valley Forge, PA

6.16M
Shares

$713 Million
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$589 Million
0.02% of portfolio
State Street Corp Boston, MA

2.18M
Shares

$253 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.81M
Shares

$209 Million
0.79% of portfolio
Allspring Global Investments Holdings, LLC

1.77M
Shares

$205 Million
0.5% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $5.89B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account